drugset / Trial / NCT07387003
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to evaluate the efficacy and safety of GZR101-80 Injection in patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs or Basal Insulin.
Timeline
- Start
- 2026-04-10
- Primary completion
- 2027-02-11
- Completion
- 2027-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR101-80 | Unknown | — | Subcutaneous |
| Comparator | GZR33 | Unknown | — | Subcutaneous |
| Comparator | Insulin aspart30 | Unknown | — | Subcutaneous |
| Comparator | Insulin degludec/Insulin aspart | Unknown | — | Subcutaneous |